Living and dying for inflammation: Neutrophils, eosinophils, basophils

Trends in Immunology

Volumn 34, Issue 8, 2013, Pages 398-409

  Geering, Barbara ^a,b   Stoeckle, Christina ^a   Conus, Sébastien ^a   Simon, Hans Uwe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Apoptosis; Cytokines; DAMPs; Granulocytes; Inflammation; PAMPs

Indexed keywords

CYTOKINE; GLYCOGEN;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; BASOPHIL; BIOLOGICAL FUNCTIONS; CELL DEATH; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; CELLS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DEATH; EOSINOPHIL; FIBROSING ALVEOLITIS; GRANULOCYTE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; LIFESPAN; MEDIATOR; MICROENVIRONMENT; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; REVIEW; RHEUMATOID ARTHRITIS; SEVERE CONGENITAL NEUTROPENIA; STORAGE DISEASE; TISSUES;

APOPTOSIS; CYTOKINES; DAMPS; GRANULOCYTES; INFLAMMATION; PAMPS;

ANIMALS; BASOPHILS; CELL DEATH; EOSINOPHILS; HUMANS; INFLAMMATION; NEUTROPHILS;

EID: 84881026932     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.04.002     Document Type: Review

References (133)

1. 2 reveals a human neutrophil lifespan of 5.4 days. Blood 2010, 116:625-627.
2. Farahi N., et al. Use of 111-Indium-labeled autologous eosinophils to establish the in vivo kinetics of human eosinophils in healthy subjects. Blood 2012, 120:4068-4071.
3. Park Y.M., Bochner B.S. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol. Res. 2010, 2:87-101.
4. Summers C., et al. Neutrophil kinetics in health and disease. Trends Immunol. 2010, 31:318-324.
5. Rankin S.M. Chemokines and adult bone marrow stem cells. Immunol. Lett. 2012, 145:47-54.
6. Mantovani A., et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519-531.
7. Jacobsen E.A., et al. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation?. J. Allergy Clin. Immunol. 2007, 119:1313-1320.
8. Karasuyama H., et al. Newly appreciated roles for basophils in allergy and protective immunity. Allergy 2011, 66:1133-1141.
9. Dibbert B., et al. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13330-13335.
10. Simon H.U., et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J. Immunol. 1997, 158:3902-3908.
11. Ohnmacht C., et al. Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity. J. Immunol. 2007, 179:4766-4774.
12. Simon H.U. Cell death in allergic diseases. Apoptosis 2009, 14:439-446.
13. Atallah M., et al. Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway. PLoS ONE 2012, 7:e29333.
14. Kobayashi T., et al. Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J. Immunol. 2010, 184:6350-6358.
15. Lotfi R., et al. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J. Immunol. 2009, 183:5023-5031.
16. Kennedy A.D., DeLeo F.R. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 2009, 43:25-61.
17. Geering B., Simon H.U. Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 2011, 18:1457-1469.
18. Risso A. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukoc. Biol. 2000, 68:785-792.
19. Kalupov T., et al. Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases. J. Biol. Chem. 2009, 284:34084-34091.
20. Condliffe A.M., et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005, 106:1432-1440.
21. Tamassia N., et al. Cutting edge: an inactive chromatin configuration at the IL-10 locus in human neutrophils. J. Immunol. 2013, 190:1921-1925.
22. Bagaitkar J., et al. Activation of neutrophil respiratory burst by fungal particles requires phosphatidylinositol 3-phosphate binding to p40(phox) in humans but not in mice. Blood 2012, 120:3385-3387.
23. Anwar A.R., et al. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology 1994, 82:222-228.
24. Simon H.U. Regulation of eosinophil and neutrophil apoptosis--similarities and differences. Immunol. Rev. 2001, 179:156-162.
25. Andina N., et al. Induction of Bim limits cytokine-mediated prolonged survival of neutrophils. Cell Death Differ. 2009, 16:1248-1255.
26. Didichenko S.A., et al. IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood 2008, 112:3949-3958.
27. Andina N., et al. Proviral integration site for Moloney murine leukemia virus 1, but not phosphatidylinositol-3 kinase, is essential in the antiapoptotic signaling cascade initiated by IL-5 in eosinophils. J. Allergy Clin. Immunol. 2009, 123:603-611.
28. Witko-Sarsat V., et al. Regulating neutrophil apoptosis: new players enter the game. Trends Immunol. 2011, 32:117-124.
29. Liew F.Y., et al. Disease-associat functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
30. Pecaric-Petkovic T., et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
31. Cherry W.B., et al. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 2008, 121:1484-1490.
32. Valent P., Dahinden C.A. Role of interleukins in the regulation of basophil development and secretion. Curr. Opin. Hematol. 2011, 17:60-66.
33. Kashyap M., et al. Thymic stromal lymphopoietin is produced by dendritic cells. J. Immunol. 2011, 187:1207-1211.
34. Morshed M., et al. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy 2012, 67:1127-1137.
35. Wong C.K., et al. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am. J. Respir. Cell Mol. Biol. 2010, 43:305-315.
36. Siracusa M.C., et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011, 477:229-233.
37. Ross E.A., et al. Interaction between integrin alpha9beta1 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis. Blood 2006, 107:1178-1183.
38. Meerschaert J., et al. Engagement of alpha4beta7 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro. J. Immunol. 1999, 163:6217-6227.
39. Bae H.B., et al. Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways. Am. J. Respir. Cell Mol. Biol. 2012, 46:790-796.
40. Cheung P.F., et al. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 2008, 180:5625-5635.
41. Pelletier M., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2009, 115:335-343.
42. Wang H., et al. Allergen challenge of peripheral blood mononuclear cells from patients with seasonal allergic rhinitis increases IL-17RB, which regulates basophil apoptosis and degranulation. Clin. Exp. Allergy 2010, 40:1194-1202.
43. + T cells. J. Leukoc. Biol. 2010, 88:1163-1170.
44. Davey M.S., et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial gammadelta T cell responses in early infection. PLoS Pathog. 2011, 7:e1002040.
45. Vukmanovic-Stejic M., et al. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 2000, 95:231-240.
46. Bhatnagar N., et al. Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood 2010, 116:1308-1316.
47. + DC and NK cells to amplify NK-derived IFN-gamma: role of CD18, ICAM-1, and ICAM-3. Blood 2011, 117:1677-1686.
48. Walker C., et al. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J. Immunol. 1998, 161:1962-1969.
49. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 2010, 10:427-439.
50. Elishmereni M., et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011, 66:376-385.
51. Walker J.A., et al. Innate lymphoid cells - how did we miss them?. Nat. Rev. Immunol. 2013, 13:75-87.
52. Mjosberg J.M., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 2011, 12:1055-1062.
53. Shaykhiev R., Bals R. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J. Leukoc. Biol. 2007, 82:1-15.
54. Wong C.K., et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007, 37:85-96.
55. Komiya A., et al. Expression and function of toll-like receptors in human basophils. Int. Arch. Allergy Immunol. 2006, 140(Suppl. 1):23-27.
56. Criss A.K., Seifert H.S. A bacterial siren song: intimate interactions between Neisseria and neutrophils. Nat. Rev. Microbiol. 2012, 10:178-190.
57. Carlyon J.A., Fikrig E. Invasion and survival strategies of Anaplasma phagocytophilum. Cell. Microbiol. 2003, 5:743-754.
58. Akahoshi T., et al. Prevention of neutrophil apoptosis by monosodium urate crystals. Rheumatol. Int. 1997, 16:231-235.
59. Ryckman C., et al. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J. Leukoc. Biol. 2004, 76:433-440.
60. Walmsley S.R., et al. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest. 2011, 121:1053-1063.
61. Nissim Ben Efraim A.H., et al. Hypoxia modulates human eosinophil function. Clin. Mol. Allergy 2010, 8:10.
62. Kottyan L.C., et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood 2009, 114:2774-2782.
63. Starkus J.G., et al. The calcium-permeable non-selective cation channel TRPM2 is modulated by cellular acidification. J. Physiol. 2010, 588:1227-1240.
64. Lammel V., et al. Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung. Lung Cancer 2012, 76:493-495.
65. Wislez M., et al. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. Am. J. Pathol. 2001, 159:1423-1433.
66. Thoren F.B., et al. Human NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism. J. Immunol. 2012, 188:1668-1674.
67. + T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 2006, 177:7155-7163.
68. + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest. 2009, 119:2898-2913.
69. Leitch A.E., et al. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Cell Death Differ. 2012, 19:1950-1961.
70. Scheel-Toellner D., et al. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 2004, 104:2557-2564.
71. Gardai S.J., et al. Oxidant-mediated mitochondrial injury in eosinophil apoptosis: enhancement by glucocorticoids and inhibition by granulocyte-macrophage colony-stimulating factor. J. Immunol. 2003, 170:556-566.
72. Zhan S., et al. Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex. Blood 1996, 88:2714-2721.
73. Leitch A.E., et al. Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents. Br. J. Pharmacol. 2009, 158:1004-1016.
74. Klausen P., et al. End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J. Leukoc. Biol. 2004, 75:569-578.
75. Milot E., Filep J.G. Regulation of neutrophil survival/apoptosis by Mcl-1. ScientificWorldJournal 2011, 11:1948-1962.
76. Akgul C., Edwards S.W. Regulation of neutrophil apoptosis via death receptors. Cell. Mol. Life Sci. 2003, 60:2402-2408.
77. Green D.R., Ferguson T.A. The role of Fas ligand in immune privilege. Nat. Rev. Mol. Cell Biol. 2001, 2:917-924.
78. Jonsson H., et al. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 2005, 11:666-671.
79. Geering B., et al. A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils. Blood 2011, 117:5953-5962.
80. Daigle I., Simon H.U. Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med. Wkly. 2001, 131:231-237.
81. Renshaw S.A., et al. Acceleration of human neutrophil apoptosis by TRAIL. J. Immunol. 2003, 170:1027-1033.
82. McGrath E.E., et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J. Leukoc. Biol. 2011, 90:855-865.
83. Daigle I., et al. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 2002, 8:61-67.
84. von Gunten S., et al. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 2005, 106:1423-1431.
85. Nutku E., et al. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 2003, 101:5014-5020.
86. Mihalache C.C., et al. Inflammation-associated autophagy-related programmed necrotic death of human neutrophils characterized by organelle fusion events. J. Immunol. 2011, 186:6532-6542.
87. Brinkmann V., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
88. Yousefi S., et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 2008, 14:949-953.
89. Fuchs T.A., et al. Novel cell death program leads to neutrophil extracellular traps. J. Cell. Biol. 2007, 176:231-241.
90. Yousefi S., et al. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 2009, 16:1438-1444.
91. Yousefi S., et al. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr. Opin. Immunol. 2012, 24:736-739.
92. Simon D., et al. Extracellular DNA traps in allergic, infectious, and autoimmune diseases. Allergy 2013, 68:409-416.
93. Prince L.R., et al. Staphylococcus aureus induces eosinophil cell death mediated by alpha-hemolysin. PLoS ONE 2012, 7:e31506.
94. Borregaard N., et al. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007, 28:340-345.
95. Maianski N.A., et al. Apoptosis of neutrophils. Acta Haematol. 2004, 111:56-66.
96. van den Berg J.M., Kuijpers T.W. Educational paper: Defects in number and function of neutrophilic granulocytes causing primary immunodeficiency. Eur. J. Pediatr. 2011, 170:1369-1376.
97. Bhatt V., Saleem A. Review: Drug-induced neutropenia--pathophysiology, clinical features, and management. Ann. Clin. Lab. Sci. 2004, 34:131-137.
98. Bianchi S.M., et al. Granulocyte apoptosis in the pathogenesis and resolution of lung disease. Clin. Sci. (Lond.) 2006, 110:293-304.
99. von Gunten S., et al. Different patterns of Siglec-9-mediated neutrophil death responses in septic shock. Shock 2009, 32:386-392.
100. Altznauer F., et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 2004, 199:1343-1354.
101. Vassina E.M., et al. cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis. Eur. J. Immunol. 2006, 36:1975-1984.
102. Hallsworth M.P., et al. Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival. Am. J. Respir. Cell Mol. Biol. 1998, 19:910-919.
103. Simon H.U. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 2003, 193:101-110.
104. Simon H.U., et al. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. Eur. J. Immunol. 2003, 33:834-839.
105. Rothenberg M.E., et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 1988, 81:1986-1992.
106. Girard D., et al. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem. J. 1997, 325:147-153.
107. Kettritz R., et al. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int. 1998, 53:84-91.
108. Gounni A.S., et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000, 96:2163-2171.
109. Hoontrakoon R., et al. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am. J. Respir. Cell Mol. Biol. 2002, 26:404-412.
110. Hu S., et al. Activation of eosinophils by IL-12 family cytokine IL-27: Implications of the pleiotropic roles of IL-27 in allergic responses. Immunobiology 2011, 216:54-65.
111. Li J.P., et al. Interleukin-27 as a negative regulator of human neutrophil function. Scand. J. Immunol. 2010, 72:284-292.
112. Bruno A., et al. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J. Immunol. 2005, 174:8090-8096.
113. Conus S., et al. Leptin is an eosinophil survival factor. J. Allergy. Clin. Immunol. 2005, 116:1228-1234.
114. Suzukawa M., et al. Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J. Immunol. 2011, 186:5254-5260.
115. Murray J., et al. Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis. Br. J. Pharmacol. 2003, 139:388-398.
116. Stehle H.W., et al. Short-chain carboxylic acids produced by gram-negative anaerobic bacteria can accelerate or delay polymorphonuclear leukocyte apoptosis in vitro. J. Periodontol. 2001, 72:1059-1063.
117. Liles W.C., et al. Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J. Leukoc. Biol. 2001, 70:96-102.
118. Lotz S., et al. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukoc. Biol. 2004, 75:467-477.
119. Brigotti M., et al. Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol. 2008, 84:1019-1027.
120. Nagase H., et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 2003, 171:3977-3982.
121. Francois S., et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol. 2005, 174:3633-3642.
122. Lindemans C.A., et al. Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism. J. Immunol. 2006, 176:5529-5537.
123. Ilmarinen P., et al. Bacterial DNA delays human eosinophil apoptosis. Pulm. Pharmacol. Ther. 2009, 22:167-176.
124. van Zandbergen G., et al. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J. Immunol. 2004, 172:1768-1776.
125. Hampton M.B., et al. Redox regulation of the caspases during apoptosis. Ann. N.Y. Acad. Sci. 1998, 854:328-335.
126. Hebestreit H., et al. Disruption of Fas receptor signaling by nitric oxide in eosinophils. J. Exp. Med. 1998, 187:415-425.
127. DeLeo F.R. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004, 9:399-413.
128. Usher L.R., et al. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J. Immunol. 2002, 168:1861-1868.
129. Cudd L.A., et al. Effects of Mannheimia haemolytica leukotoxin on apoptosis and oncosis of bovine neutrophils. Am. J. Vet. Res. 2001, 62:136-141.
130. Russo T.A., et al. E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:207-216.
131. Ward C., et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J. Immunol. 2002, 168:6232-6243.
132. Yoshimura-Uchiyama C., et al. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin. Exp. Allergy 2004, 34:1283-1290.
133. Conus S., et al. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 2008, 205:685-698.